Preview

The Clinician

Advanced search

Clinical case of peripartum cardiomyopathy in the third trimester of pregnancy

https://doi.org/10.17650/1818-8338-2019-12-3-4-45-50

Abstract

The aim of the work was to study the clinical case of a rare heart disease — peripartum cardiomyopathy.

Materials and methods. The puerperal, 34 years old, was admitted to the regional cardiologic dispensary from the regional perinatal center after an emergency cesarean section at 37 weeks of gestation with complaints on short of breath, heaviness in the interscapular region, dyspnea at little exertion and rest, cough with light colored phlegm.

Results. Based on anamnesis data (infection at the 22nd week of pregnancy), the clinical picture (symptoms of heart failure from the 36th week of gestation), instrumental research data, a clinical diagnosis was made: Peripartum cardiomyopathy. Echocardiography has become one of the main diagnostic methods that made it possible to verify the diagnosis. Dilatation of the left atrium and left ventricle, reduction of the left ventricular ejection fraction to 40 % and pulmonary hypertension were revealed. The recovery of heart systolic function occurred after 6 months (increasing of the left ventricular ejection fraction up to 58 %).

Conclusion. This clinical case is interesting because this rare for Russia disease developed in the third trimester of pregnancy (according to literary data, it often occurs after childbirth). Because of the unstable patient»s condition, an emergency caesarean section was performed, that saved the life of the mother and child. Restoration of heart systolic function occurred after 6 months.

About the Authors

V. A. Fomina
Ryazan Regional Clinical Cardiological Dispensary
Russian Federation

96 Stroykova St., Ryazan 390026



O. V. Evsina
Ryazan State Medical University named after academician I.P. Pavlov, Ministry of Health of Russia;
Russian Federation

9 Vysokovoltnaya St., Ryazan 390026



E. A. Glazkova
Ryazan Regional Clinical Cardiological Dispensary
Russian Federation

96 Stroykova St., Ryazan 390026



V. S. Agafonova
Ryazan Regional Clinical Cardiological Dispensary
Russian Federation

96 Stroykova St., Ryazan 390026



K. A. Tkachenko
Ryazan State Medical University named after academician I.P. Pavlov, Ministry of Health of Russia
Russian Federation

9 Vysokovoltnaya St., Ryazan 390026



References

1. Porak C. De L’influence reciproque de la grossesse et des maladies du Coeur [thesis]. Medical Faculty of Paris. France, 1880.

2. Hull E., Hafkesbring E. “Toxic” postpartal heart disease. N Orleans Med Surg J 1937;89:550-7.

3. Demakis J. G., Rahimtoola S. H., Sutton G. C. et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44(6):1053-61. PMID: 4256828.

4. Sliwa K., Hilfiker-Kleiner D., Petrie M. C. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum сardiomyopathy. Eur J Heart Fail 2010;12(8):767-78. DOI: 10.1093/eurjhf/hfq120.

5. Sliwa K., Fett J., Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368(9536):687-93. DOI: 10.1016/S0140-6736(06)69253-2.

6. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:3147-97. DOI: 10.1093/eurheartj/ehr218. PMID: 21873418.

7. Abboud J., Murad Y., Chen-Scarabelli C. et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007;118(3):295-303. DOI: 10.1016/j.ijcard.2006.08.005. PMID: 17208320.

8. Sliwa K., Forster O., Libhaber E. et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27(4):441-6. DOI: 10.1093/eurheartj/ehi481. PMID: 16143707.

9. Arany Z., Elkayam U. Peripartum сardiomyopathy. Circulation 2016;133(14):1397—409. DOI: 10.1161/CIRCULATIONAHA.115.020491. PMID: 27045128.

10. Midei M. G., DeMent S. H., Feldman A. M. et al. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81(3):922-8. PMID: 2306840.

11. Fett J. D. Viral particles in endomyocardial biopsy tissue from peripartum cardiomyopathy patients. Am J Obstet Gynecol 2006;195(1):330—1; author reply 331-2. DOI: 10.1016/j.ajog.2005.10.810. PMID: 16813763.

12. Elkayam U., Akhter M. W., Singh H. et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111(16):2050—5. DOI: 10.1161/01.CIR.0000162478.36652.7E. PMID: 15851613.

13. Ramaraj R., Sorrell V. L. Peripartum cardiomyopathy. Causes, diagnosis, and treatment. Cleveland Clin J Med 2009;76(5):289-96. DOI: 10.3949/ccjm.76a.08004. PMID: 19414544.

14. Halkein J., Tabruyn S. P., Ricke-Hoch M. et al. MicroRNA- 146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123(5):2143— 54. DOI: 10.1172/JCI64365. PMID: 23619365.

15. Hibbard J. U., Lindheimer M., Lang R. M. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999;94(2):311-6. PMID: 10432149.

16. Kurbanov R. D., Abdullaev T. A., Mirzarakhimova S. T., Mardanov B. U. Po stpartum(peripartal) cardiomyopathy: some features of the clinical picture and the course of the disease. Cardiologiya = Cardiology 2012;52(6):35—9. (In Russ.).

17. Savchenko T.N., Agaeva M. I., Dergacheva I. A. Anemia and pregnancy. Russkij medicinskij zhurnal = Russian Medical Journal. 2016;24(15):971-5. (In Russ.).

18. Garg J., Palaniswamy C., Lanier G. M. Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and management. Cardiol Rev 2015;23(2):69—78. DOI: 10.1097/CRD.0000000000000038. PMID: 25111318.

19. Vatutin N. T., Taradin G. G., Popelnukhina L. G. et al. Treatment of peripartum cardiomyopathy (review). Arhiv’ vnutrennej mediciny = Archive of Internal Medicine 2017;7(5):340—9. (In Russ.). DOI: 10.20514/2226-6704-2017-7-5-340-349.

20. Terekhovskaya Yu. V., Smirnova E. A. Heart rhythm disorders in pregnancy. [Nauka molodyh (Eruditio Juvenium) = Science of Youth (Eruditio Juvenium) 2017;5(3):462—80. (In Russ.).

21. Pyatt J. R. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J 2011;87(1023):34—9. DOI: 10.1136/pgmj.2009.096594. PMID: 20935342.

22. Chaves R. G., Lamounier J. A. Breastfeeding and maternal medications. Journal de Pediatria 2004;80(5):189—98. DOI: 10.2223/JPED.1246. PMID: 15583770.

23. Dinic V., Markovic D., Savic N. et al. Peripartum cardiomyopathy in intensive care unit: an update. Front Med (Lausanne) 2015;2:82. DOI: 10.3389/fmed.2015.00082. PMID: 26636086.

24. Kiselev A. M., Konovalov O. E. Reproductive women’s health of late fertile age as a medical and social problem. Rossijskij mediko-biologicheskij vestnik imeni akademika I. P. Pavlova = I. P. Pavlov Russian Medical Biological Herald 2011;19(2):12—4. (In Russ.).


Review

For citations:


Fomina V.A., Evsina O.V., Glazkova E.A., Agafonova V.S., Tkachenko K.A. Clinical case of peripartum cardiomyopathy in the third trimester of pregnancy. The Clinician. 2018;12(3-4):45-50. (In Russ.) https://doi.org/10.17650/1818-8338-2019-12-3-4-45-50

Views: 1251


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8338 (Print)
ISSN 2412-8775 (Online)